• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Affimed Ord Shs (NQ: AFMD )

    5.030 +0.150 (+3.07%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 48,580
    Open 5.050
    Bid (Size) 4.510 (10)
    Ask (Size) 5.240 (3)
    Prev. Close 4.880
    Today's Range 4.880 - 5.190
    52wk Range 0.2235 - 7.240
    Shares Outstanding 15,227,463
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
    From Affimed N.V.
    Via GlobeNewswire
    AFMD Stock Earnings: Affimed Beats EPS, Misses Revenue for Q4 2023
    AFMD stock results show that Affimed beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    +704.80%
    +704.80%
    1 Month
    -5.63%
    -5.63%
    3 Month
    +785.56%
    +785.56%
    6 Month
    +1485.25%
    +1485.25%
    1 Year
    +458.89%
    +458.89%

    More News

    Read More
    Affimed Reports 2023 Financial Results and Operational Progress
    From Affimed N.V.
    Via GlobeNewswire
    A Preview Of Affimed's Earnings
    Via Benzinga
    Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
    From Affimed N.V.
    Via GlobeNewswire
    Recap: Affimed Q3 Earnings
    Via Benzinga
    Earnings Scheduled For March 28, 2024
    Via Benzinga
    ASTR Stock Alert: Astra Space Is Going Private
    Via InvestorPlace
    Why Is AerSale (ASLE) Stock Down 18% Today?
    Via InvestorPlace
    Why Is Affimed (AFMD) Stock Moving Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    7 of the Best Speculative Stocks You Can Snag for Less Than $1
    Via InvestorPlace
    Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Affimed Announces 1-for-10 Reverse Stock Split
    From Affimed N.V.
    Via GlobeNewswire
    Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
    From Affimed N.V.
    Via GlobeNewswire
    Affimed Announces Leadership Change and Organizational Restructuring
    From Affimed N.V.
    Via GlobeNewswire
    Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
    From Affimed N.V.
    Via GlobeNewswire
    3 Penny Stocks That Are Too Compelling to Ignore
    Via InvestorPlace
    Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients
    From Affimed N.V.
    Via GlobeNewswire
    Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
    From Affimed N.V.
    Via GlobeNewswire
    Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24
    From Affimed N.V.
    Via GlobeNewswire
    Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
    From Affimed N.V.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.